TP53 and central nervous system cancer: Among the five frequently mutated glioma genes (BRAF, IDH1, TP53, IDH1, and H3F3A), BRAF and H3F3A mutation rates continuously decreased as patient ages increased from pediatric to AYAs and to OAs.